Search Result "QWBA"
An Effective QWBA/UHPLC-MS/Tissue Punch Approach: Solving a Pharmacokinetic Issue via Quantitative Met-ID
Journal: Drug Metabolism Letters
Volume: 14 Issue: 2 Year: 2021 Page: 152-162
Author(s): József Pánczél,Manfred Schudok,Matthias Schiell,Jens Riedel,Vilmos Kertesz
Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans
Journal: Drug Metabolism Letters
Volume: 9 Issue: 1 Year: 2015 Page: 28-47
Author(s): Ramesh Jayaraman,Mohammed Khalid Pasha,Anthony Williams,Kee Cee Goh,Kantharaj Ethirajulu
Recent Progress on Mass Spectrum Based Approaches for Absorption, Distribution,Metabolism, and Excretion Characterization of Traditional Chinese Medicine
Journal: Current Drug Metabolism
Volume: 23 Issue: 2 Year: 2022 Page: 99-112
Author(s):
Whole-Body Autoradiography In Drug Discovery
Journal: Current Drug Metabolism
Volume: 3 Issue: 5 Year: 2002 Page: 451-462
Author(s): E. G. Solon, S. K. Balani, F. W. Lee
Applications of LC-MS in PET Radioligand Development and Metabolic Elucidation
Journal: Current Drug Metabolism
Volume: 11 Issue: 6 Year: 2010 Page: 483-493
Author(s): Ying Ma, Dale O. Kiesewetter, Lixin Lang, Dongyu Gu, Xiaoyuan Chen
The Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry
Journal: Current Drug Metabolism
Volume: 7 Issue: 2 Year: 2006 Page: 183-203
Author(s): Andreas Reichel
Gauging Reactive Metabolites in Drug-Induced Toxicity
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 4 Year: 2015 Page: 465-489
Author(s): Marsha R. Eno, Michael D. Cameron
The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 25 Year: 2015 Page: 2954-2971
Author(s): Natalia Rosso,Veronica Marin,Antonio Giordani,Stefano Persiani,Federica Sala,Lucio Cavicchioli,Lucio C. Rovati,Claudio Tiribelli
Manufacturing of [14C]-Labeled Drug Substance and Drug Product Utilized in Clinical Research: A Case Study of Omecamtiv Mecarbil
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 5 Year: 2016 Page: 609-615
Author(s): Scott W. Roberts, Jeroen M. Bezemer, Michael T. Kennedy, Tiffany L. Correll, Raju Subramanian, Shawn D. Walker
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 3 Year: 2011 Page: 254-284
Author(s): B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes, M. A. Palladino